Substantive outcome improvement and savings to Medicaid may be achieved with small changes in prescribing rates or comorbidity prevalence among patients with heart failure.
Ian M. Breunig, PhD
Advertisement
Articles by Ian M. Breunig, PhD
Advertisement
Latest Updated Articles
- Disease-Modifying Therapy and Hospitalization Risk in Heart Failure Patients
Published: January 20th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets
3
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
4
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
5